114 related articles for article (PubMed ID: 2435620)
1. Characterization of newly established human ovarian carcinoma cell line--special reference of the effects of cis-platinum on cellular proliferation and release of CA125.
Ishiwata I; Ishiwata C; Soma M; Nozawa S; Ishikawa H
Gynecol Oncol; 1987 Mar; 26(3):340-54. PubMed ID: 2435620
[TBL] [Abstract][Full Text] [Related]
2. Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I; Inaba N; Ota Y; Sato N; Shirotake S; Iwasawa H; Sekiya S; Takamizawa H; Suzuki N; Tokita H
Arch Gynecol Obstet; 1988; 243(2):69-81. PubMed ID: 3165255
[TBL] [Abstract][Full Text] [Related]
3. Establishment and characterization of a human malignant choroids plexus papilloma cell line (HIBCPP).
Ishiwata I; Ishiwata C; Ishiwata E; Sato Y; Kiguchi K; Tachibana T; Hashimoto H; Ishikawa H
Hum Cell; 2005 Mar; 18(1):67-72. PubMed ID: 16130902
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component).
Ishiwata I; Ishiwata C; Soma M; Ishikawa H
Gynecol Oncol; 1986 Sep; 25(1):95-107. PubMed ID: 3732924
[TBL] [Abstract][Full Text] [Related]
5. [Establishment and characterization of a CA125-producing human ovarian clear cell carcinoma cell line].
Sasa H; Ishii K; Hirata J; Kikuchi Y; Nagata I; Kawai T; Senoo A; Sugita M; Sugishita T; Tenjin Y
Hum Cell; 1993 Dec; 6(4):279-86. PubMed ID: 8148309
[TBL] [Abstract][Full Text] [Related]
6. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of a cisplatin-resistant human ovarian cancer cell line].
Sasa H; Hisano A; Ishii K; Hirata J; Kikuchi Y; Nagata I; Senoo A; Aida S; Tamai S; Sugita M
Hum Cell; 1993 Jun; 6(2):106-13. PubMed ID: 8217948
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of a cell line derived from a human serous surface papillary carcinoma of the ovary.
Kobayashi Y; Mizuhara H; Ohara T; Kondo H; Sato S; Kiguchi K; Ishizuka B; Ishiwata I; Tadokoro M
Hum Cell; 2006 Nov; 19(4):133-7. PubMed ID: 17257376
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of a human liposarcoma cell line (HTLS) from the retroperitoneal liposarcoma.
Kiguchi K; Ishiwata I; Ishiwata E; Koshitaka Y; Ohara T; Okudai Y; Sato S; Kobayashi Y; Ishizuka B; Ishikawa H
Hum Cell; 2005 Mar; 18(1):45-52. PubMed ID: 16130899
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a hormone-producing ovarian carcinoma cell line.
Poels LG; Jap PH; Ramaekers FF; Scheres JM; Thomas CM; Vooijs PG; Croes HJ; Mungyer G
Gynecol Oncol; 1989 Feb; 32(2):203-14. PubMed ID: 2463217
[TBL] [Abstract][Full Text] [Related]
11. [Study of the mechanism of tumor marker CA125 in serum].
Kiyozuka Y; Noda T; Adachi S; Adachi S; Akada S; Ichijo M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Dec; 41(12):1951-8. PubMed ID: 2592818
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Krukenberg tumor cell line, especially the biological relationship between cancer and stromal cells.
Ishiwata I; Ishiwata C; Soma M; Ono I; Nakaguchi T; Nozawa S; Ishikawa H
Exp Pathol; 1990; 38(2):97-108. PubMed ID: 2160890
[TBL] [Abstract][Full Text] [Related]
13. [Establishment and characterization of a human ovarian adenocarcinoma cell line OC-8611].
Huang JS
Zhonghua Zhong Liu Za Zhi; 1989 Nov; 11(6):416-8. PubMed ID: 2634538
[TBL] [Abstract][Full Text] [Related]
14. Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma.
Ishiwata I; Nozawa S; Inoue T; Okumura H
Cancer Res; 1977 Jun; 37(6):1777-85. PubMed ID: 858140
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of a human ovarian serous cystadenocarcinoma cell line that produces the tumor markers CA-125 and tissue polypeptide antigen.
Imai S; Kiyozuka Y; Maeda H; Noda T; Hosick HL
Oncology; 1990; 47(2):177-84. PubMed ID: 2314830
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a human ovarian endodermal sinus tumor cell line--producing specific type of alpha-fetoprotein subfraction.
Ishiwata I; Ishiguro T; Ishiwata C; Soma M; Ishikawa H
Gynecol Oncol; 1986 Nov; 25(3):281-93. PubMed ID: 2430863
[TBL] [Abstract][Full Text] [Related]
17. Characterization of newly established cell line HUOA from a human ovarian serous cystadenocarcinoma.
Ishiwata I; Ishiwata C; Kobayashi N; Ishikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1987 May; 39(5):831-6. PubMed ID: 3598277
[TBL] [Abstract][Full Text] [Related]
18. [Identification and characterization of stem cells in an ovarian cancer cell line and examination their drug resistance].
Wei Z; Wang Y; Yu X; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 2015 Jun; 50(6):452-7. PubMed ID: 26311554
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a human ovarian carcinoma cell line: UCI 101.
Fuchtner C; Emma DA; Manetta A; Gamboa G; Bernstein R; Liao SY
Gynecol Oncol; 1993 Feb; 48(2):203-9. PubMed ID: 8428692
[TBL] [Abstract][Full Text] [Related]
20. Ovarian tumor-specific antigens.
Knauf S; Urbach GI
Am J Obstet Gynecol; 1974 Aug; 119(7):966-70. PubMed ID: 4135399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
